Delivery Order SPE2DB20D1100-SPE2DB24FY43C
Award Date 10/13/23
Potential Completion Date 10/16/23
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,875.69 Firm Fixed Price Delivery Order supports the procurement of 4,563,373,292 units of Lamictal 100 mg tablets for the DLA. The contract has a completion date of January 22, 2024 and was awarded on January 19, 2024. There was no set-aside designation for this contract. AmerisourceBergen holds a $999,999,999...
- This federal contract award is a delivery order valued at $21,224.00 issued to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is for the supply of 100 mg Lamictal tablets. Amerisourcebergen is a major pharmaceutical distributor that holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
- This contract award, with ID SPE2DB24D1205|SPE2DB25FCUNS, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,173.88 firm fixed-price delivery order is for the supply of LAMICTAL 25 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, identified as SPE2DB22D1017|SPE2DB25FG0GR, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,070.74 firm-fixed-price delivery order is for the supply of 4,567,942,237 units of the medication Lamictal 150 mg tablet. The contract has an ultimate completion date of April 17, 2025 and does not utilize any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,128.00 firm fixed-price delivery order contract is for the provision of LAMICTAL XR 250 MG TABLET 30S, a pharmaceutical product. The contract has a June 26, 2024 completion date and does not include any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,052.90, is a Firm Fixed Price Delivery Order for the supply of LAMICTAL 200 MG TABLET 60S. The contract has an ultimate completion date of July 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,069.63, is a delivery order for the supply of LAMICTAL 150 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of January 10, 2024 and is a firm fixed-price arrangement. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product LAMICTAL 150 MG TABLET 60S. The contract has a potential value of $1,211.96 and a performance period through February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period...
- This federal contract award is for the delivery of pharmaceutical products, specifically LAMICTAL 200 MG TABLET 60S, to the Defense Logistics Agency (DLA). The $11,630.02 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, with ID SPE2DB22D1202|SPE2DB23FHPE5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,439.57 Firm Fixed Price delivery order is for the supply of Lamictal 100 mg tablets to support the DLA's medical supply needs. The contract has a completion date of May 12, 2023 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999...